Neurosurgery

Uzm. Dr. Ebubekir Akpınar

Doctor and researcher Başakşehir Çam ve Sakura Şehir Hastanesi İstanbul
Pituitary NeoplasmsAdenomaNeuroendocrine TumorsBrain Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Pituitary Neoplasms 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Adenoma 6 publications
  • Neuroendocrine Tumors 3 publications
  • Brain Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNeurosurgerysaglik.gov.trFrom source
  • InstitutionBaşakşehir Çam ve Sakura Şehir Hastanesisaglik.gov.trFrom source
  • Area of workPituitary NeoplasmsExtracted from 9 publications · Model version —From source
  • Publications39 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0002-4069-0021ORCIDFrom source
  • Last synchronised5 November 2026 10:36https://camsakurasehir.saglik.gov.tr/TR-1203080/gorev-yapan-hekimlerimiz.html#ebubekir-akpinarsaglik.gov.tr

Scientific work

Publications on Pituitary Neoplasms

39 publications

  1. Direct Graftless Internal Maxillary Artery–Middle Cerebral Artery Bypass via a Combined Sublabial Transmaxillary–Pterional Corridor: Cadaveric Study With 3-Dimensional Models

    Operative Neurosurgery, 2026

    DOI 10.1227/ons.0000000000002195 PMID 42714567 Source: OpenAlex

  2. ANATOMICAL LANDMARKS AND BOUNDARIES OF THE ENDOSCOPIC SUBLABIAL TRANSMAXILLARY APPROACH TO THE MIDDLE CRANIAL FOSSA: A CADAVERIC STUDY

    Turkish Neurosurgery, 2026

    DOI 10.5137/1019-5149.jtn.49296-26.4 PMID 42836533 Source: OpenAlex

  3. Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022

    Pituitary, 2026

    DOI 10.1007/s11102-026-01691-9 PMID 42126653 Open-access full textSource: ORCID

  4. Calcitonin Gene-Related Peptide Expression in Somatotroph Adenomas: Implications for Clinical Course and Treatment Outcomes

    Neuroendocrinology, 2026

    DOI 10.1159/000551012 PMID 41746852 Source: ORCID

  5. Multimodal management of giant prolactinoma with extensive amyloid spherule deposition: a case report with review of the literature

    Endocrine Journal, 2026

    DOI 10.1507/endocrj.ej26-0079 PMID 42203477 2 citations (Europe PMC) Open-access full textSource: ORCID

  6. Hair cortisol outperforms urinary free cortisol in diagnosing Cushing’s syndrome: a cross-sectional study

    Hormones (Athens, Greece), 2026

    DOI 10.1007/s42000-025-00750-3 PMID 41540319 2 citations (OpenAlex) Source: OpenAlex

  7. Lineage-specific steroidomic signatures in pituitary neuroendocrine tumors: pregnenolone enrichment in SF-1 lineage and associations with tumor behavior

    Endocrine Related Cancer, 2026

    DOI 10.1530/erc-26-0154 PMID 42333631 Source: OpenAlex

  8. EP1201 - ECE_2150 - Intracranial dissemination in aggressive immature PIT-1 lineage pituitary tumor: a consequence of repeated transcranial surgery?

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag096.1452 Open-access full textSource: OpenAlex

  9. EP1163 - ECE_2787 - Prognostic role of granulation pattern in Cushing's disease: clinical and surgical implications

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag096.1418 Open-access full textSource: OpenAlex

  10. Hematological changes in Cushing's disease from diagnosis to remission: comparison with non-functioning pituitary adenomas

    Endokrynologia Polska, 2026

    DOI 10.5603/ep.111457 PMID 42549627 Open-access full textSource: Europe PMC

View all 39 publications